A pharmaceutical company buys old drugs and increases the pricemultifold, a profitable business...Andrew PollackSabrina Tavernise
The Centers for Medicare and Medicaid Services won’t send a bill to drug companies until 2025, but the federal agency has already started tracking drug prices. The agency on Wednesday identified 27 drugs whose prices were increased too fast, a move that will limit the price that Medicare enro...
TRENTON, N.J. (AP) — Drug companies are still raising prices for brand-name prescription medicines, just not as often or by as much as they used to, according to an Associated Press analysis.
This will put an end to a self-declared halt on price hikes earlier this year after pharmaceutical companies came under pressure from President Trump. Pfizer & others should be ashamed that they have raised drug prices for no reason. They are merely taking advantage of the poor & others ...
"It is not surprising that drug pricing and reimbursement constraints remain the number one concern for the industry, especially since 2020 kicked off with drug companies in the United States again raising prices for several hundred drugs," said Bonnie Bain, GlobalData’s global head of pharma. ...
Drug companies are still raising prices for brand-name prescription medicines, just not as often or by as much as they used to, according to an Associated Press analysis. After years of frequent list price hikes, many drugmakers are showing some restraint, according to the analysis of drug ...
Investigators focused on 10 drugmakers they accuse of raising prices for common brand-name drugs by nearly four times the rate of inflation over the past five years. "The committee's investigation has pulled back the curtain on drug companies' unfair, unjustified, always-increasing drug prices,"...
The Industry Conundrum: Curbing Rising Drug Prices While Keeping Pharma Firms Profitable Earlier this year the news that big pharma was raising the price of more than 1,000 drugs created outrage nationwide. As an example of soaring prices, according to a recent indus...
US Drug Industry Middlemen Defend Business Model Amid Accusations of Raising Patient Costs More Reuters FILE PHOTO: CVS Executive Vice President and President of Pharmacy Services David Joyner listens as others testify before a Senate Health, Education, Labor and Pensions Committee heari...
Composition and method for nutritional supplement for drug abuse treatment and rehabilitation A cost-effective multi-drug nutritional treatment approach in combination form comprising a specific protocol of specific nutritional supplements for different types of addictions within the distinct phases of recovery...